MARKET WIRE NEWS
  1. Home
  2. Stock
  3. CLLS
  4. News
CLLS
Quote
Short
News
Articles
Message Board

Cellectis S.A. (NASDAQ : CLLS ) News

Cellectis S.A. (NASDAQ: CLLS) News Releases

CLLS News Releases
CLLS : NASDAQ
SeekingAlpha
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
CLLS : NASDAQ
SeekingAlpha
Biggest stock movers Wednesday: CBRL, CLLS, SMCI, chip stocks, and more
CLLS : NASDAQ
SeekingAlpha
Cellectis wins FDA RMAT status for leukemia CAR-T candidate lasme-cel; shares rise
CLLS : NASDAQ
GlobeNewswire
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL
CLLS : NASDAQ
KlickAnalytics
CLLS Price Target Alert: $9.00. Issued by Barclays
CLLS : NASDAQ
KlickAnalytics
Overweight Recommendation Issued On CLLS By Barclays
CLLS : NASDAQ
GlobeNewswire
Cellectis' Annual Shareholders General Meeting to be Held on June 25, 2026
CLLS : NASDAQ
GlobeNewswire
Cellectis to Present Clinical Data on Lasme-cel and Eti-cel at EHA 2026 Annual Congress
CLLS : NASDAQ
SeekingAlpha
Cellectis GAAP EPS of -$0.18, revenue of $12.02M
CLLS : NASDAQ
GlobeNewswire
Cellectis Reports Financial Results for the First Quarter 2026
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.